Mutascio S, Mota T, Franchitti L, Sharma AA, Willemse A, Bergstresser SN, Wang H, Statzu M, Tharp GK, Weiler J, Sékaly R-P, Bosinger SE, Paiardini M, Silvestri G, Jones RB, Kulpa DA, Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA A Cancer J Clinicians. 2023;73:17–48. https://doi.org/10.3322/caac.21763.

Article  Google Scholar 

Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W, Zhao Y, Caron C, Chan Y-Y, Lee CK, Xu X, Zhang J, Masubuchi T, Wu C, Bui JD, Hui E. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584–90. https://doi.org/10.1097/CM9.0000000000002108.

Article  PubMed  Google Scholar 

Alvarez CA, Ramirez-Cepeda F, Santana P, Torres E, Cortes J, Guzman F, Schmitt P, Mercado L. Insights into the diversity of NOD-like receptors: Identification and expression analysis of NLRC3, NLRC5 and NLRX1 in rainbow trout. Mol Immunol. 2017;87:102–13. https://doi.org/10.1016/j.molimm.2017.03.010.

Article  CAS  PubMed  Google Scholar 

Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Abedi V, Bassaganya-Riera J. NLRX1 Modulates immunometabolic mechanisms controlling the host-gut microbiota interactions during inflammatory bowel disease. Front Immunol. 2018;9:363. https://doi.org/10.3389/fimmu.2018.00363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE. 2008;3: e2119. https://doi.org/10.1371/journal.pone.0002119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, Ting JP-Y. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008;451:573–7. https://doi.org/10.1038/nature06501.

Article  CAS  PubMed  Google Scholar 

Allen IC. Non-inflammasome forming NLRs in inflammation and tumorigenesis. Front Immunol. 2014;5:169. https://doi.org/10.3389/fimmu.2014.00169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koblansky AA, Truax AD, Liu R, Montgomery SA, Ding S, Wilson JE, Brickey WJ, Muhlbauer M, McFadden RM, Hu P, Li Z, Jobin C, Lund PK, Ting JP. The innate immune receptor NLRX1 functions as a tumor suppressor by reducing colon tumorigenesis and key tumor-promoting signals. Cell Rep. 2016;14:2562–75. https://doi.org/10.1016/j.celrep.2016.02.064.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei A, Maloy KJ. Colon cancer in the land of NOD: NLRX1 as an intrinsic tumor suppressor. Trends Immunol. 2016;37:569–70. https://doi.org/10.1016/j.it.2016.07.004.

Article  CAS  PubMed  Google Scholar 

Tattoli I, Killackey SA, Foerster EG, Molinaro R, Maisonneuve C, Rahman MA, Winer S, Winer DA, Streutker CJ, Philpott DJ, Girardin SE. NLRX1 acts as an epithelial-intrinsic tumor suppressor through the modulation of TNF-mediated proliferation. Cell Rep. 2016;14:2576–86. https://doi.org/10.1016/j.celrep.2016.02.065.

Article  CAS  PubMed  Google Scholar 

Lei Y, Wen H, Yu Y, Taxman DJ, Zhang L, Widman DG, Swanson KV, Wen K-W, Damania B, Moore CB, Giguère PM, Siderovski DP, Hiscott J, Razani B, Semenkovich CF, Chen X, Ting JP-Y. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity. 2012;36:933–46. https://doi.org/10.1016/j.immuni.2012.03.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costford SR, Tattoli I, Duan FT, Volchuk A, Klip A, Philpott DJ, Woo M, Girardin SE. Male mice lacking NLRX1 are partially protected from high-fat diet-induced hyperglycemia. J Endocr Soc. 2018;2:336–47. https://doi.org/10.1210/js.2017-00360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh K, Roy M, Prajapati P, Lipatova A, Sripada L, Gohel D, Singh A, Mane M, Godbole MM, Chumakov PM, Singh R. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells. Biochim Biophys Acta Mol Basis Dis. 2019. https://doi.org/10.1016/j.bbadis.2019.02.018.

Article  PubMed  PubMed Central  Google Scholar 

Stokman G, Kors L, Bakker PJ, Rampanelli E, Claessen N, Teske GJD, Butter L, van Andel H, van den Bergh Weerman MA, Larsen PWB, Dessing MC, Zuurbier CJ, Girardin SE, Florquin S, Leemans JC. NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity. J Exp Med. 2017;214:2405–20. https://doi.org/10.1084/jem.20161031.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian DY, Ding YS, Chen GF, Ding JJ, Chen YX, Lu TF, Wang ZX, Smego RA. A placebo-controlled clinical trial of prednisone in the treatment of early hemorrhagic fever. J Infect Dis. 1990;162:1213–4. https://doi.org/10.1093/infdis/162.5.1213.

Article  CAS  PubMed  Google Scholar 

Leber A, Hontecillas R, Zoccoli-Rodriguez V, Bienert C, Chauhan J, Bassaganya-Riera J. Activation of NLRX1 by NX-13 alleviates inflammatory bowel disease through immunometabolic mechanisms in CD4+ T Cells. J Immunol. 2019;203:3407–15. https://doi.org/10.4049/jimmunol.1900364.

Article  CAS  PubMed  Google Scholar 

Killackey SA, Bi Y, Soares F, Hammi I, Winsor NJ, Abdul-Sater AA, Philpott DJ, Arnoult D, Girardin SE. Mitochondrial protein import stress regulates the LC3 lipidation step of mitophagy through NLRX1 and RRBP1. Mol Cell. 2022;82:2815-2831.e5. https://doi.org/10.1016/j.molcel.2022.06.004.

Article  CAS  PubMed  Google Scholar 

Arnoult D, Soares F, Tattoli I, Castanier C, Philpott DJ, Girardin SE. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci. 2009;122:3161–8. https://doi.org/10.1242/jcs.051193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez-Torres RJ, Chamaillard M. The ubiquitin code of NODs signaling pathways in health and disease. Front Immunol. 2019;10:2648. https://doi.org/10.3389/fimmu.2019.02648.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caruso R, Warner N, Inohara N, Nunez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41:898–908. https://doi.org/10.1016/j.immuni.2014.12.010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Correa RG, Milutinovic S, Reed JC. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep. 2012;32:597–608. https://doi.org/10.1042/BSR20120055.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF, Cantley LC. The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment. Cell. 2018;174:1347–60. https://doi.org/10.1016/j.cell.2018.08.027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, Duran M, Pauli C, Shaw C, Chadalavada K, Rajasekhar VK, Genovese G, Venkatesan S, Birkbak NJ, McGranahan N, Lundquist M, LaPlant Q, Healey JH, Elemento O, Chung CH, Lee NY, Imielenski M, Nanjangud G, Pe’er D, Cleveland DW, Powell SN, Lammerding J, Swanton C, Cantley LC. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467–72. https://doi.org/10.1038/nature25432.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coutermarsh-Ott S, Eden K, Allen IC. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure. J Gen Virol. 2016;97:825–38. https://doi.org/10.1099/jgv.0.000401.

Article  CAS  PubMed  PubMed Central  Google Scholar